asa guidelines on glp-1 semaglutide Perioperative Use of Receptor Agonists in Patients Undergoing Cardiac Procedures: A Scoping Review Don't miss the August ASA

I just want you to know we're still waiting on big definitive results here, especially when we talk about Alzheimer's

The hypoglycemic strategy has also shifted from sugar control to both sugar control and heart protection

Several local providers have pharmaceutical research backgrounds, which means they approach GLP-1 prescribing from a clinical data perspective rather than a trends-and-marketing one

Separate from diabetic retinopathy, recent research has examined whether semaglutide or tirzepatide may be associated with an increased risk of optic nerve disorders, including non-arteritic anterior ischemic optic neuropathy, or NAION